Neurologic Manifestations of Hospitalized Patients With Coronavirus Disease 2019 in Wuhan, China
Неврологические проявления у госпитализированных пациентов с коронавирусной болезнью 2019 в Ухане, Китай
2020-04-10
SCID: 54.1/5m2smbq9
Discuss with AI
COVID-19Neurologic manifestationsWuhan, Chinadifferential diagnosishospitalized patientssevere acute respiratory syndrome coronavirus 2
Figures from the paper
Abstract (AI)
Importance: The outbreak of coronavirus disease 2019 (COVID-19) in Wuhan, China, is serious and has the potential to become an epidemic worldwide. Several studies have described typical clinical manifestations including fever, cough, diarrhea, and fatigue. However, to our knowledge, it has not been reported that patients with COVID-19 had any neurologic manifestations. Objective: To study the neurologic manifestations of patients with COVID-19. Design, Setting, and Participants: This is a retrospective, observational case series. Data were collected from January 16, 2020, to February 19, 2020, at 3 designated special care centers for COVID-19 (Main District, West Branch, and Tumor Center) of the Union Hospital of Huazhong University of Science and Technology in Wuhan, China. The study included 214 consecutive hospitalized patients with laboratory-confirmed diagnosis of severe acute respiratory syndrome coronavirus 2 infection. Main Outcomes and Measures: Clinical data were extracted from electronic medical records, and data of all neurologic symptoms were checked by 2 trained neurologists. Neurologic manifestations fell into 3 categories: central nervous system manifestations (dizziness, headache, impaired consciousness, acute cerebrovascular disease, ataxia, and seizure), peripheral nervous system manifestations (taste impairment, smell impairment, vision impairment, and nerve pain), and skeletal muscular injury manifestations. Results: Of 214 patients (mean [SD] age, 52.7 [15.5] years; 87 men [40.7%]) with COVID-19, 126 patients (58.9%) had nonsevere infection and 88 patients (41.1%) had severe infection according to their respiratory status. Overall, 78 patients (36.4%) had neurologic manifestations. Compared with patients with nonsevere infection, patients with severe infection were older, had more underlying disorders, especially hypertension, and showed fewer typical symptoms of COVID-19, such as fever and cough. Patients with more severe infection had neurologic manifestations, such as acute cerebrovascular diseases (5 [5.7%] vs 1 [0.8%]), impaired consciousness (13 [14.8%] vs 3 [2.4%]), and skeletal muscle injury (17 [19.3%] vs 6 [4.8%]). Conclusions and Relevance: Patients with COVID-19 commonly have neurologic manifestations. During the epidemic period of COVID-19, when seeing patients with neurologic manifestations, clinicians should suspect severe acute respiratory syndrome coronavirus 2 infection as a differential diagnosis to avoid delayed diagnosis or misdiagnosis and lose the chance to treat and prevent further transmission.
Key Findings
1
Clinicians should consider SARS-CoV-2 infection as a differential diagnosis when encountering patients with neurologic manifestations during the COVID-19 epidemic.
2
Failure to suspect COVID-19 in patients with neurologic symptoms can lead to delayed diagnosis, misdiagnosis, missed treatment opportunities, and increased risk of transmission.
3
Patients with COVID-19 commonly have neurologic manifestations.
Research Object
Hospitalized patients with Coronavirus Disease 2019 (COVID-19) in Wuhan, China
Research Subject
Neurologic manifestations (occurrence, recognition, and implications for diagnosis and prevention of transmission) in these hospitalized COVID-19 patients
Publication Details
Publication Date
2020-04-10
Journal
Publisher
ISSN
Cited by
7166
Open access PDF
Access Type
Author Information
Download PDF
Subscribe to digest
References available in scid.ai4
A Novel Coronavirus from Patients with Pneumonia in China, 20192020
A pneumonia outbreak associated with a new coronavirus of probable bat origin2020
Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis2004
Diagnosis and Treatment of Adults with Community-acquired Pneumonia. An Official Clinical Practice Guideline of the American Thoracic Society and Infectious Diseases Society of America2019
Cited by20
Pathophysiology, Transmission, Diagnosis, and Treatment of Coronavirus Disease 2019 (COVID-19): A Review2020
Psychiatric and neuropsychiatric presentations associated with severe coronavirus infections: a systematic review and meta-analysis with comparison to the COVID-19 pandemic2020
Neurological associations of COVID-192020
Olfactory transmucosal SARS-CoV-2 invasion as a port of central nervous system entry in individuals with COVID-192020
Role of angiotensin-converting enzyme 2 (ACE2) in COVID-192020
The emerging spectrum of COVID-19 neurology: clinical, radiological and laboratory findings2020
Neuroinvasion of SARS-CoV-2 in human and mouse brain2020
Risk of Ischemic Stroke in Patients With Coronavirus Disease 2019 (COVID-19) vs Patients With Influenza2020
Pulmonary Arterial Thrombosis in COVID-19 With Fatal Outcome: Results From a Prospective, Single-Center, Clinicopathologic Case Series2020
SARS-CoV-2 and Stroke in a New York Healthcare System2020
Stroke in COVID-19: A systematic review and meta-analysis2020
Neurologic Involvement in Children and Adolescents Hospitalized in the United States for COVID-19 or Multisystem Inflammatory Syndrome2021
COVID-19 neuropathology at Columbia University Irving Medical Center/New York Presbyterian Hospital2021
Cerebrovascular disease in patients with COVID-19: neuroimaging, histological and clinical description2020
Does SARS‐Cov‐2 invade the brain? Translational lessons from animal models2020
The blood-brain barrier is dysregulated in COVID-19 and serves as a CNS entry route for SARS-CoV-22022
Neurological and Neuropsychiatric Impacts of COVID-19 Pandemic2020
Neuropathology and virus in brain of SARS-CoV-2 infected non-human primates2022
Histopathological observations in COVID-19: a systematic review2020
COVID-19 and possible links with Parkinson’s disease and parkinsonism: from bench to bedside2020